We examined the relation of carcinoembryonic antigen levels to time, site and extent of recurrence in 358 patients with colorectal cancer. The recurrence rate was higher in patients with Dukes' B and Dukes' C lesions who had preoperative levels higher than 5 ng per milliliter. There was a linear inverse correlation between preoperative levels and estimated mean time to recurrence in patients with Dukes' B and C lesions, ranging from 30 months for a level of 2 to 9.8 months for a level of 70 ng per milliliter. In patients with Dukes' C lesions the median time to recurrence was 13 months if preoperative levels were higher than 5 ng per milliliter, and 28 months if they were lower. Preoperative carcinoembryonic antigen levels in patients with resectable Dukes' B and C cancer provided an additional criterion for allocating these patients to groups at high or low risk for recurrence.
This article has been cited by other articles:
Wolpin, B. M., Meyerhardt, J. A., Mamon, H. J., Mayer, R. J.
(2007). Adjuvant Treatment of Colorectal Cancer. CA Cancer J Clin
57: 168-185
[Abstract][Full Text]
Gasser, M., Gerstlauer, C., Grimm, M., Bueter, M., Lebedeva, T., Lutz, J., Maeder, U., Ribas, C., Ribas, C., Nichiporuk, E., Thalheimer, A., Heemann, U., Thiede, A., Meyer, D., Waaga-Gasser, A. M.
(2007). Comparative Analysis of Predictive Biomarkers for Therapeutical Strategies in Colorectal Cancer. Ann. Surg. Oncol.
14: 1272-1284
[Abstract][Full Text]
Jacobsen, P. B., Shibata, D., Siegel, E. M., Druta, M., Lee, J.-H., Marshburn, J., Davenport, L., Cruse, H., Levine, R., Gondi, A., Brown, R., Malafa, M.
(2007). Measuring Quality of Care in the Treatment of Colorectal Cancer: The Moffitt Quality Practice Initiative. J Oncol Pract
3: 60-65
[Abstract][Full Text]
Nissan, A., Stojadinovic, A., Shia, J., Hoos, A., Guillem, J. G., Klimstra, D., Cohen, A. M., Minsky, B. D., Paty, P. B., Wong, W. D.
(2006). Predictors of Recurrence in Patients With T2 and Early T3, N0 Adenocarcinoma of the Rectum Treated by Surgery Alone. JCO
24: 4078-4084
[Abstract][Full Text]
Park, Y.-A., Lee, K. Y., Kim, N. K., Baik, S. H., Sohn, S. K., Cho, C. W.
(2006). Prognostic Effect of Perioperative Change of Serum Carcinoembryonic Antigen Level: A Useful Tool for Detection of Systemic Recurrence in Rectal Cancer. Ann. Surg. Oncol.
13: 645-650
[Abstract][Full Text]
De Pascalis, R., Iwahashi, M., Tamura, M., Padlan, E. A., Gonzales, N. R., Santos, A. D., Giuliano, M., Schuck, P., Schlom, J., Kashmiri, S. V. S.
(2002). Grafting of "Abbreviated" Complementarity-Determining Regions Containing Specificity-Determining Residues Essential for Ligand Contact to Engineer a Less Immunogenic Humanized Monoclonal Antibody. J. Immunol.
169: 3076-3084
[Abstract][Full Text]
Brunagel, G., Vietmeier, B. N., Bauer, A. J., Schoen, R. E., Getzenberg, R. H.
(2002). Identification of Nuclear Matrix Protein Alterations Associated with Human Colon Cancer. Cancer Res.
62: 2437-2442
[Abstract][Full Text]
Duffy, M. J.
(2001). Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is It Clinically Useful?. Clin. Chem.
47: 624-630
[Abstract][Full Text]
Guadagni, F., Kantor, J., Aloe, S., Carone, M. D., Spila, A., DAlessandro, R., Abbolito, M. R., Cosimelli, M., Graziano, F., Carboni, F., Carlini, S., Perri, P., Sciarretta, F., Greiner, J. W., Kashmiri, S. V. S., Steinberg, S. M., Roselli, M., Schlom, J.
(2001). Detection of Blood-borne Cells in Colorectal Cancer Patients by Nested Reverse Transcription-Polymerase Chain Reaction for Carcinoembryonic Antigen Messenger RNA: Longitudinal Analyses and Demonstration of Its Potential Importance as an Adjunct to Multiple Serum Markers. Cancer Res.
61: 2523-2532
[Abstract][Full Text]